American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 696-699 , November 2007

Early Fistula Failure: Back to Basics

  • Laura M. Dember, MD

      Affiliations

    • Boston University School of Medicine, Boston, Massachusetts
    • Corresponding Author InformationAddress correspondence to Laura M. Dember, MD, Renal Section, EBRC 504, Boston University School of Medicine, 650 Albany St, Boston, MA 02118.
    • ,
  • Bradley S. Dixon, MD

      Affiliations

    • Veterans Affairs Medical Center, University of Iowa School of Medicine, Iowa City, Iowa

References 

  1. Centers for Medicare and Medicaid Services. 2004 Annual Report (End-Stage Renal Disease Clinical Performance Measures Project). Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Center for Beneficiary Choices; 2004;
  2. Roy-Chaudhury P, Arend L, Zhang J, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50:782–790
  3. Schwab SJ, Harrington JT, Singh A, et al. Vascular access for hemodialysis. Kidney Int. 1999;55:2078–2090
  4. Schwab SJ, Oliver MJ, Suhocki P, McCann R. Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow. Kidney Int. 2001;59:358–362
  5. Kanterman RY, Vesely TM, Pilgram TK, Guy BW, Windus DW, Picus D. Dialysis access grafts: anatomic location of venous stenosis and results of angioplasty. Radiology. 1995;195:135–139
  6. Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int. 1992;42:1390–1397
  7. Besarab A, Sullivan KL, Ross RP, Moritz MJ. Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int. 1995;47:1364–1373
  8. Moist LM, Churchill DN, House AA, et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol. 2003;14:2645–2653
  9. Chang CJ, Ko PJ, Hsu LA, et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004;43:74–84
  10. Roy-Chaudhury P, Kelly BS, Miller MA, et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001;59:2325–2334
  11. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients (Clinical, immunocytochemical, light and electron microscopic assessment). Circulation. 1989;80:1726–1736
  12. Rekhter M, Nicholls S, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb. 1993;13:609–617
  13. Dixon BS, Beck GJ, Dember LM, et al. Design of the dialysis access consortium (DAC) aggrenox prevention of access stenosis trial. Clin Trials. 2005;2:400–412
  14. Masaki T, Rathi R, Zentner G, et al. Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int. 2004;66:2061–2069
  15. Kuji T, Masaki T, Goteti K, et al. Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis. Kidney Int. 2006;69:2179–2185
  16. Rotmans JI, Pattynama PM, Verhagen HJ, et al. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation. 2005;111:1537–1542
  17. Kelly B, Melhem M, Zhang J, Kasting G, Li J, Krishnamoorthy M, et al. Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant. 2006;21:2425–2431
  18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  19. Fistula First National Vascular Access Improvement Initiative. www.fistulafirst.org. Accessed September 17, 2007.
  20. Centers for Medicare and Medicaid Services. 2005 Annual Report (End-Stage Renal Disease Clinical Performance Measures Project). Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Center for Beneficiary Choices; 2005;
  21. Dixon BS. Why don’t fistulas mature?. Kidney Int. 2006;70:1413–1422
  22. Lockhart ME, Robbin ML, Allon M. Preoperative sonographic radial artery evaluation and correlation with subsequent radiocephalic fistula outcome. J Ultrasound Med. 2004;23:161–168
  23. Turmel-Rodrigues L, Mouton A, Birmele B, et al. Salvage of immature forearm fistulas for haemodialysis by interventional radiology. Nephrol Dial Transplant. 2001;16:2365–2371
  24. Beathard GA, Arnold P, Jackson J, Litchfield T. Aggressive treatment of early fistula failure. Kidney Int. 2003;64:1487–1494
  25. Eyden B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol. 2001;25:39–50
  26. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol. 2007;170:1807–1816

PII: S0272-6386(07)01252-8

doi: 10.1053/j.ajkd.2007.09.006

American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 696-699 , November 2007

Article Tools

* Image Usage & Resolution